Proliposomal drug delivery system

Details for Australian Patent Application No. 2002256353 (hide)

Owner Western Center for Drug Development, College of Pharmacy, Western University of Health Sciences

Inventors Betageri, Guru V.

Agent Davies Collison Cave

Pub. Number AU-B-2002256353

PCT Pub. Number WO2002/085304

Priority 09/931,399 16.08.01 US; 60/286,386 25.04.01 US

Filing date 24 April 2002

Wipo publication date 5 November 2002

Acceptance publication date 16 August 2007

International Classifications

A61K 9/06 (2006.01) Medicinal preparations characterised by special physical form - Ointments

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/30 (2006.01) Medicinal preparations characterised by special physical form - Organic coatings

A61K 9/32 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/36 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 9/54 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/58 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/60 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/133 (2006.01) - having hydroxy groups, e.g. sphingosine

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/568 (2006.01) - substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone

A61K 35/64 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/04 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/14 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

A61K 47/24 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

Event Publications

17 April 2003 Application Open to Public Inspection

  Published as AU-B-2002256353

16 August 2007 Application Accepted

  Published as AU-B-2002256353

13 December 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002256354-STEERABLE CATHETER WITH SHAFT SUPPORT SYSTEM FOR RESISTING AXIAL COMPRESSIVE LOADS

2002256352-PROSTANOIDS AUGMENT OCULAR DRUG PENETRATION